Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Children's Oncology Group
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Washington University School of Medicine
M.D. Anderson Cancer Center
BeiGene
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Canadian Cancer Trials Group
AbbVie
Children's Oncology Group
St. Jude Children's Research Hospital
EpicentRx, Inc.
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Klinikum Oldenburg gGmbH
University of Utah
Children's Oncology Group
Cavion
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Grupo Español de Investigación en Neurooncología
National Cancer Institute (NCI)
Dana-Farber Cancer Institute